SAN DIEGO, Sept. 19, 2019 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) merchandise, nowadays announced its intention to file for a Request of Continued Examination (“RCE”) of its patent application No. 15/426,617 with the US Patent Trademark Workplace (“USPTO”), titled Pharmaceutical Formulations Containing Cannabidiol and Nicotine For Treating Smokeless Tobacco Addiction. The intent to file an RCE follows USPTO notifying the Business that the Patent Trial and Appeal Board (“PTAB”) had rejected the Company’s appeal to overturn the examiner’s choice to deny particular claims produced inside the Company’s patent application.
“While the USPTO choice is disappointing, it is crucial to recognize that this is not the finish of the course of action and we strategy to request continued examination,” mentioned Joseph Dowling, Chief Executive Officer of CV Sciences. “We stay confident in safeguarding our intellectual house surrounding these formulations and our capacity to commercialize this invention, which we think can offer a remedy to a lingering epidemic in smokeless tobacco use. We will continue to concentrate on building merchandise that enhance the top quality of life of our clients.”
About CV Sciences, Inc.
CV Sciences, Inc. (OTCQB:CVSI) operates two distinct organization segments: a customer item division focused on manufacturing, advertising and promoting plant-primarily based CBD merchandise to a variety of marketplace sectors and a drug improvement division focused on building and commercializing CBD-primarily based novel therapeutics using CBD. The Company’s PlusCBD™ Oil is the prime-promoting brand of hemp-derived CBD on the marketplace, according to SPINS, the top provider of syndicated information and insights for the all-natural, organic and specialty merchandise sector. CV Sciences’ state-of-the-art facility follows all suggestions for Fantastic Manufacturing Practices (GMP) and the Company’s complete spectrum hemp extracts are processed, made, and tested all through the manufacturing course of action to confirm the cannabinoid content material meets strict business requirements. With a commitment to science, PlusCBD™ Oil was the initial hemp CBD supplement brand to invest in the scientific proof important to get self-affirmed Frequently Recognized as Secure (GRAS) status.CV Sciences, Inc. has major offices and facilities in San Diego, California. Additional data is out there from OTCMarkets.com or by going to www.cvsciences.com.
This press release may possibly include particular forward-searching statements and data, as defined inside the which means of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is topic to the Secure Harbor made by these sections. This material consists of statements about anticipated future events and/or monetary final results that are forward-searching in nature and topic to dangers and uncertainties. Such forward-searching statements by definition involve dangers, uncertainties.
Make contact with Details:
Investor Make contact with:
Scott Van Winkle
Media Make contact with: